KAUST and SFDA shaping the future of Saudi medical tech

Summary

SFDA and KAUST jointly held a workshop to discuss AI and biotechnology in medical devices. The workshop included a leadership panel with the CEO of SFDA and the President of KAUST. SFDA emphasized the Kingdom's adoption of the National Biotechnology Strategy and its focus on improving the quality of life. Why it matters: The collaboration signals Saudi Arabia's intent to be a leader in biotechnology, leveraging AI to improve healthcare and attract investment.